In the absence of a submission from the holder of the marketing authorisation, clobazam (Perizam®) cannot be endorsed for use within NHS Wales as an adjunctive therapy in epilepsy in children aged between 2 years and 6 years old, if standard treatment with one or more anticonvulsants has failed: treatment of simple or complex partial epilepsy with or without secondary generalisation and treatment of all types of generalised epilepsy (tonic/clonic, myoclonic, absence seizures).